NCT01762501
Azilsartan Circadian and Sleep Pressure
See it on ClinicalTrials.gov ↗718 people
43.7%
56.3%
314 womenmiddle line = equal numbers404 men
- Phase
- NA
- Paid for by
- Sogo Rinsho Médéfi Co., Ltd.
- Finished
- 2013-12
- Health conditions
- Hypertension
- Who could join
- Anyone
- Ages
- 20 Years – no maximum
- Average age
- mean 61 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No pregnant women
Women who were pregnant could not join.
“Pregnant, possible to being pregnant, or lactating woman”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Pregnant, possible to being pregnant, or lactating woman”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“I. Cardiac disease: Myocardial infarction, coronary artery revascularization II. Cerebrovascular-disease: cerebral infarction, cerebral hemorrhage, transient ischemic attack III. Progressive hypertensive retinopathy: hemorrhage, exudation,…”
- No cancer
Women with current or past cancer were turned away.
“Secondary hypertension, grade III hypertension (sitting systolic blood pressure greater than or equal to 180 mmHg or sitting diastolic blood pressure greater than or equal to 110 mmHg), malignant hypertension”
Study titles and rules are shown in their original English.